Core Laboratories Inc (CLB)

$16.69

-0.55

(-3.19%)▲

Market is closed - opens 7 PM, 18 Apr 2024

Insights on Core Laboratories Inc

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 125.34M → 128.21M (in $), with an average increase of 2.2% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, 22.84M → 6.46M (in $), with an average decrease of 44.8% per quarter

  • Vs FTI

    In the last 1 year, Technipfmc Plc has given 90.2% return, outperforming this stock by 114.3%

  • Vs FTI

    In the last 3 years, Technipfmc Plc has given 248.6% return, outperforming this stock by 288.0%

Performance

  • $16.56
    $17.29
    $16.69
    downward going graph

    0.78%

    Downside

    Day's Volatility :4.19%

    Upside

    3.44%

    downward going graph
  • $13.82
    $27.90
    $16.69
    downward going graph

    17.2%

    Downside

    52 Weeks Volatility :50.47%

    Upside

    40.18%

    downward going graph

Returns

PeriodCore Laboratories IncSector (Energy)Index (Russel 2000)
3 Months
6.1%
17.8%
0.0%
6 Months
-32.04%
2.4%
0.0%
1 Year
-24.14%
8.8%
-1.5%
3 Years
-39.0%
94.5%
-21.8%

Highlights

Market Capitalization
811.0M
Book Value
$4.8
Dividend Share
0.04
Dividend Yield
0.23%
Earnings Per Share (EPS)
0.51
PE Ratio
33.8
PEG Ratio
2.15
Wall Street Target Price
19.38
Profit Margin
7.19%
Operating Margin TTM
13.18%
Return On Assets TTM
6.05%
Return On Equity TTM
17.68%
Revenue TTM
509.8M
Revenue Per Share TTM
10.92
Quarterly Revenue Growth YOY
0.5%
Gross Profit TTM
96.1M
EBITDA
72.1M
Diluted Eps TTM
0.51
Quarterly Earnings Growth YOY
-0.72
EPS Estimate Current Year
0.88
EPS Estimate Next Year
1.19
EPS Estimate Current Quarter
0.19
EPS Estimate Next Quarter
0.19

Analyst Recommendation

Hold
    0
    0%Buy
    53%Hold
    46%Sell
Based on 15 Wall street analysts offering stock ratings for Core Laboratories Inc(by analysts ranked 0 to 5 stars)
Based on 15 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
00
00
00
Hold
8
8
8
Sell
7
7
7

Analyst Forecast

What analysts predicted

Upside of 16.12%

Current $16.69
Target $19.38

Company Financials

FY18Y/Y Change
Revenue
700.8M
↑ 6.22%
Net Income
79.5M
↓ 4.33%
Net Profit Margin
11.35%
↓ 1.25%
FY19Y/Y Change
Revenue
668.2M
↓ 4.66%
Net Income
102.0M
↑ 28.24%
Net Profit Margin
15.26%
↑ 3.91%
FY20Y/Y Change
Revenue
487.3M
↓ 27.08%
Net Income
-97.1M
↓ 195.19%
Net Profit Margin
-19.92%
↓ 35.18%
FY21Y/Y Change
Revenue
470.3M
↓ 3.49%
Net Income
19.7M
↓ 120.32%
Net Profit Margin
4.19%
↑ 24.11%
FY22Y/Y Change
Revenue
489.7M
↑ 4.14%
Net Income
19.5M
↓ 1.39%
Net Profit Margin
3.97%
↓ 0.22%
FY23Y/Y Change
Revenue
509.8M
↑ 4.1%
Net Income
36.7M
↑ 88.53%
Net Profit Margin
7.19%
↑ 3.22%
Q3 FY22Q/Q Change
Revenue
126.0M
↑ 4.19%
Net Income
7.5M
↑ 6.48%
Net Profit Margin
5.97%
↑ 0.13%
Q4 FY22Q/Q Change
Revenue
127.6M
↑ 1.27%
Net Income
6.8M
↓ 10.27%
Net Profit Margin
5.29%
↓ 0.68%
Q1 FY23Q/Q Change
Revenue
128.4M
↑ 0.62%
Net Income
2.4M
↓ 64.85%
Net Profit Margin
1.85%
↓ 3.44%
Q2 FY23Q/Q Change
Revenue
127.9M
↓ 0.37%
Net Income
22.8M
↑ 862.75%
Net Profit Margin
17.87%
↑ 16.02%
Q3 FY23Q/Q Change
Revenue
125.3M
↓ 1.98%
Net Income
9.3M
↓ 59.48%
Net Profit Margin
7.39%
↓ 10.48%
Q4 FY23Q/Q Change
Revenue
128.2M
↑ 2.29%
Net Income
6.5M
↓ 30.18%
Net Profit Margin
5.04%
↓ 2.35%
FY18Y/Y Change
Total Assets
648.8M
↑ 10.95%
Total Liabilities
487.9M
↑ 11.89%
FY19Y/Y Change
Total Assets
774.7M
↑ 19.4%
Total Liabilities
592.5M
↑ 21.44%
FY20Y/Y Change
Total Assets
568.6M
↓ 26.6%
Total Liabilities
493.0M
↓ 16.8%
FY21Y/Y Change
Total Assets
580.9M
↑ 2.16%
Total Liabilities
419.9M
↓ 14.84%
FY22Y/Y Change
Total Assets
578.4M
↓ 0.43%
Total Liabilities
389.4M
↓ 7.25%
FY23Y/Y Change
Total Assets
586.4M
↑ 1.39%
Total Liabilities
356.6M
↓ 8.43%
Q3 FY22Q/Q Change
Total Assets
570.2M
↓ 1.27%
Total Liabilities
386.9M
↓ 4.18%
Q4 FY22Q/Q Change
Total Assets
578.4M
↑ 1.43%
Total Liabilities
389.4M
↑ 0.65%
Q1 FY23Q/Q Change
Total Assets
593.6M
↑ 2.64%
Total Liabilities
393.5M
↑ 1.04%
Q2 FY23Q/Q Change
Total Assets
601.8M
↑ 1.39%
Total Liabilities
382.2M
↓ 2.85%
Q3 FY23Q/Q Change
Total Assets
592.4M
↓ 1.57%
Total Liabilities
363.0M
↓ 5.04%
Q4 FY23Q/Q Change
Total Assets
586.4M
↓ 1.02%
Total Liabilities
356.6M
↓ 1.76%
FY18Y/Y Change
Operating Cash Flow
111.8M
↓ 10.01%
Investing Cash Flow
-70.6M
↑ 243.63%
Financing Cash Flow
-42.5M
↓ 59.19%
FY19Y/Y Change
Operating Cash Flow
89.5M
↓ 19.94%
Investing Cash Flow
-5.7M
↓ 91.96%
Financing Cash Flow
-85.9M
↑ 102.19%
FY20Y/Y Change
Operating Cash Flow
57.9M
↓ 35.36%
Investing Cash Flow
7.9M
↓ 238.29%
Financing Cash Flow
-63.0M
↓ 26.63%
FY21Y/Y Change
Operating Cash Flow
36.6M
↓ 36.79%
Investing Cash Flow
-10.2M
↓ 230.21%
Financing Cash Flow
-22.5M
↓ 64.35%
FY22Y/Y Change
Operating Cash Flow
25.0M
↓ 31.78%
Investing Cash Flow
-3.9M
↓ 62.28%
Financing Cash Flow
-23.4M
↑ 4.08%
Q3 FY22Q/Q Change
Operating Cash Flow
5.9M
↑ 866.94%
Investing Cash Flow
-2.6M
↓ 8.19%
Financing Cash Flow
-5.7M
↑ 53.92%
Q4 FY22Q/Q Change
Operating Cash Flow
13.2M
↑ 125.83%
Investing Cash Flow
-3.9M
↑ 50.8%
Financing Cash Flow
-12.6M
↑ 120.23%
Q1 FY23Q/Q Change
Operating Cash Flow
-3.2M
↓ 123.99%
Investing Cash Flow
-2.0M
↓ 47.15%
Financing Cash Flow
6.1M
↓ 148.23%
Q2 FY23Q/Q Change
Operating Cash Flow
8.8M
↓ 377.09%
Investing Cash Flow
-3.4M
↑ 66.24%
Financing Cash Flow
1.2K
↓ 99.98%
Q3 FY23Q/Q Change
Operating Cash Flow
-215.9K
↓ 102.46%
Investing Cash Flow
-3.4M
↑ 0.0%
Financing Cash Flow
-6.0M
↓ 497328.51%

Technicals Summary

Sell

Neutral

Buy

Core Laboratories Inc is currently in a neutral trading position according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Core Laboratories Inc
Core Laboratories Inc
3.86%
-32.04%
-24.14%
-39.0%
-77.39%
Baker Hughes Company
Baker Hughes Company
-1.14%
-10.36%
8.54%
59.86%
47.08%
Schlumberger Limited
Schlumberger Limited
-4.9%
-16.14%
-2.61%
91.52%
11.52%
Technipfmc Plc
Technipfmc Plc
3.09%
21.48%
90.24%
248.08%
3.64%
Weatherford International Plc
Weatherford International Plc
-2.14%
16.89%
70.46%
761.9%
761.9%
Halliburton Company
Halliburton Company
0.88%
-11.8%
12.28%
84.03%
22.2%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Core Laboratories Inc
Core Laboratories Inc
33.8
33.8
2.15
0.88
0.18
0.06
0.0
4.8
Baker Hughes Company
Baker Hughes Company
16.81
16.81
0.96
2.01
0.13
0.05
0.03
15.4
Schlumberger Limited
Schlumberger Limited
17.72
17.72
1.24
3.32
0.22
0.08
0.02
14.14
Technipfmc Plc
Technipfmc Plc
210.67
210.67
14.01
1.14
0.01
0.04
0.01
7.42
Weatherford International Plc
Weatherford International Plc
20.09
20.09
2.62
7.09
0.61
0.1
NA
12.83
Halliburton Company
Halliburton Company
13.16
13.16
3.91
3.41
0.31
0.11
0.02
10.56
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Core Laboratories Inc
Core Laboratories Inc
Hold
$811.0M
-77.39%
33.8
7.19%
Baker Hughes Company
Baker Hughes Company
Buy
$32.2B
47.08%
16.81
7.62%
Schlumberger Limited
Schlumberger Limited
Buy
$73.7B
11.52%
17.72
12.68%
Technipfmc Plc
Technipfmc Plc
Buy
$11.1B
3.64%
210.67
0.29%
Weatherford International Plc
Weatherford International Plc
Buy
$8.2B
761.9%
20.09
8.12%
Halliburton Company
Halliburton Company
Buy
$34.1B
22.2%
13.16
11.46%

Institutional Holdings

  • Ariel Investments, LLC

    19.26%

  • BlackRock Inc

    17.10%

  • Vanguard Group Inc

    11.50%

  • Earnest Partners LLC

    7.99%

  • BTIM Corp

    4.87%

  • State Street Corporation

    4.37%

Corporate Announcements

  • Core Laboratories Inc Dividends March,2024

    In the quarter ending March,2024. Core Laboratories Inc has declared dividend of $0.01

    Read More

Company Information

core laboratories is a leading provider of proprietary and patented reservoir description and production enhancement services. core laboratories remains dedicated to providing the technology you need to enhance your production. we continue to develop and acquire technologies that complement our existing products and services, and we disseminate these technologies throughout our global network. with over 70 offices in more than 50 countries located in major oil-producing provinces, core laboratories provides services to the world's major, national, and independent oil companies. we can help you solve your reservoir problems. core laboratories'​ reservoir optimization technologies are used to increase total recovery from existing fields. our services enable our clients to optimize reservoir performance and maximize hydrocarbon recovery from their producing fields. core laboratories has taken extensive measures to ensure the services and data provided by all of our worldwide companies are

Organization
Core Laboratories Inc
Employees
3600
CEO
Mr. Lawrence V. Bruno
Industry
Industrial Services

Discover More

FAQs